Статья

Immunity to COVID-19 and issues of screening for SARS-COV-2 antibodies

N. Mayanskiy,
2021

This paper briefly presents the known data on the immune response to SARS-CoV-2, and also analyzes the possibilities and limitations of serological testing for antibodies that should be accounted for when planning population studies and interpreting their results. © 2020 Pirogov Russian National Research Medical University. All rights reserved.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • N. Mayanskiy
    Pirogov Russian National Research Medical University, Moscow, Russian Federation
Название журнала
  • Bulletin of Russian State Medical University
Выпуск
  • 3
Страницы
  • 25-27
Ключевые слова
  • SARS-CoV-2 antibody; Article; coronavirus disease 2019; false positive result; human; immune response; screening test; seroconversion; seroepidemiology; virus immunity
Издатель
  • Pirogov Russian National Research Medical University
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus